P453 DUPILUMAB A HUMAN ANTI-INTERLEUKIN-4 RECEPTOR ALPHA MONOCLONAL ANTIBODY FOR UNCONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS.

2019 ◽  
Vol 123 (5) ◽  
pp. S59
Author(s):  
S. Nsouli
Author(s):  
Matteo Trimarchi ◽  
Pietro Indelicato ◽  
Alessandro Vinciguerra ◽  
Mario Bussi

Chronic rhinosinusitis with nasal polyps is a type 2-mediated inflammatory disease associated with significant burden due to symptoms and high recurrence rate after surgery. Dupilumab, a monoclonal antibody against the interleukin-4 receptor subunit α, has demonstrated good clinical efficacy and acceptable safety in phase II and phase III trials.


2014 ◽  
Vol 42 (5) ◽  
pp. 465-471 ◽  
Author(s):  
M. Nabavi ◽  
S. Arshi ◽  
A. Bahrami ◽  
Z. Aryan ◽  
M.H. Bemanian ◽  
...  

2018 ◽  
Vol 9 ◽  
Author(s):  
Hlumani Ndlovu ◽  
Justin Komguep Nono ◽  
Nada Abdel Aziz ◽  
Natalie Eva Nieuwenhuizen ◽  
Frank Brombacher

2016 ◽  
Vol 46 (10) ◽  
pp. 2311-2321 ◽  
Author(s):  
Lucy H. Jackson-Jones ◽  
Dominik Rückerl ◽  
Freya Svedberg ◽  
Sheelagh Duncan ◽  
Rick M. Maizels ◽  
...  

Cytokine ◽  
2000 ◽  
Vol 12 (11) ◽  
pp. 1656-1661 ◽  
Author(s):  
Haiyan Liu ◽  
Richard A Prayson ◽  
Melinda L Estes ◽  
Judith A Drazba ◽  
Gene H Barnett ◽  
...  

2017 ◽  
Vol 31 (1) ◽  
pp. e8-e12 ◽  
Author(s):  
Zhenxiao Huang ◽  
Jayakar V. Nayak ◽  
Yan Sun ◽  
Qian Huang ◽  
Bing Zhou

Background Analysis of recent research indicated that T-helper cells may play an important role in the pathogenesis of chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). Objective The purpose of this study was to investigate the peripheral blood Th1 and Th2 cells and eosinophil population in patients with CRS. Methods Peripheral blood samples were obtained from nine nonatopic controls, 37 patients with CRSsNP, and 66 patients with CRSwNP. The samples were then analyzed by flow cytometry analysis (Th1 cell [CD4+, interleukin 4−, interferon γ+]; and Th2 cell [CD4+, interleukin 4+, interferon γ−]). The patients were stratified into four groups based on their allergic status by using skin-prick test results and immunoglobulin E level measurements as the following: (1) nonatopic CRSsNP, (2) nonatopic CRSwNP, (3) atopic CRSsNP, and (4) atopic CRSwNP. Eosinophil counts were also compared. The severity of nasal diseases in these patients was assessed via the Lund-Mackay score. Results No significant differences in peripheral blood Th1 and Th2 cells were found among all the atopic, nonatopic CRS groups, and the nonatopic control groups. Peripheral blood eosinophil levels in atopic CRSwNP were significantly elevated compared with the nonatopic controls (p < 0.05), but no significant difference was found among all atopic and nonatopic CRS groups. Conclusion Analysis of our data demonstrated that a proportion of systemic Th1- and Th2-skewed lymphocytes in all CRS groups were similar to that in healthy subjects, irrespective of atopic status. The patients with CRSwNP and with atopy but not the patients with CRSsNP and with atopy demonstrated systemic eosinophilic inflammation. Further studies are needed to investigate underlying pathophysiologic mechanism or endotypes.


Sign in / Sign up

Export Citation Format

Share Document